INT313271

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.24
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 4
Disease Relevance 0.06
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (GRIN1, GRIN2B) transport (GRIN2B)
GRIN1 (Homo sapiens)
GRIN2B (Homo sapiens)
Pain Link Frequency Relevance Heat
intrathecal 24 41.56 Quite Low
Calcium channel 4 31.68 Quite Low
potassium channel 16 26.64 Quite Low
imagery 36 5.00 Very Low Very Low Very Low
headache 24 5.00 Very Low Very Low Very Low
Electroencephalography 24 5.00 Very Low Very Low Very Low
Inflammation 8 5.00 Very Low Very Low Very Low
Glutamate receptor 8 5.00 Very Low Very Low Very Low
ketamine 4 5.00 Very Low Very Low Very Low
withdrawal 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 48 56.32 Quite High
Encephalitis 20 50.00 Quite Low
Cancer 84 48.80 Quite Low
Convulsion 60 5.00 Very Low Very Low Very Low
Lymphocytosis 48 5.00 Very Low Very Low Very Low
Recurrence 48 5.00 Very Low Very Low Very Low
Infection 32 5.00 Very Low Very Low Very Low
Movement Disorders 28 5.00 Very Low Very Low Very Low
Syndrome 28 5.00 Very Low Very Low Very Low
Fever 24 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
These results confirmed the specificity of the antibodies for NMDAR and for the NR1 (Dalmau et al., 2008), but we continue to use the NR1/NR2B combination for diagnostic assays in order not to miss any possible binding to NR2B.


NR1 Binding (binding) of NR2B
1) Confidence 0.24 Published 2010 Journal Brain Section Body Doc Link PMC2877907 Disease Relevance 0 Pain Relevance 0
These results confirmed the specificity of the antibodies for NMDAR and for the NR1 (Dalmau et al., 2008), but we continue to use the NR1/NR2B combination for diagnostic assays in order not to miss any possible binding to NR2B.


NMDAR Binding (binding) of NR2B
2) Confidence 0.21 Published 2010 Journal Brain Section Body Doc Link PMC2877907 Disease Relevance 0 Pain Relevance 0
NR1-specific commercial antibodies (anti-NR1) precipitated large amounts of EGFP-NR1 which was not bound by NR2B-specific (anti-NR2B) or PSD95 (anti-PSD95) antibodies (data from three experiments).
EGFP-NR1 Binding (bound) of NR2B
3) Confidence 0.21 Published 2010 Journal Brain Section Body Doc Link PMC2877907 Disease Relevance 0.06 Pain Relevance 0
These results confirmed the specificity of the antibodies for NMDAR and for the NR1 (Dalmau et al., 2008), but we continue to use the NR1/NR2B combination for diagnostic assays in order not to miss any possible binding to NR2B.


NR1 Binding (binding) of NR2B
4) Confidence 0.21 Published 2010 Journal Brain Section Body Doc Link PMC2877907 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox